← Leaderboards
Lewis Schwartz
Efemoral Medical, Inc.
$2,126,052
Attributed
$2,126,052
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,126,052 · 2
By mechanism
R44$1,976,052 · 1
R43$150,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Disability”
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Susan M Landau · University Of California Berkeley$47,252,026
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Alan D. Palkowitz · Indiana University Indianapolis$20,460,525
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$16,767,001
Research focus
DisabilityEffectivenessCostDilatation - ActionAmericanAffectAgingCoronaryDesignDiagnosisArterial Occlusive DiseasesArteriesAtherectomyAmputationBalloon AngioplastyBalloon DilatationBypassCharacteristicsBiologyChronicAntiproliferative DrugsDevicesBlood VesselsEnvironment
Grant awards (3)
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System)$1,192,988
R44 · FY2023 · HL · contact PI
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System)$783,064
R44 · FY2022 · HL · contact PI
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF SERIAL, BALLOON-EXPANDABLE, PACLITAXEL-ELUTING RESORBABLE SCAFFOLDS (the Efemoral Device)$150,000
R43 · FY2019 · HL · contact PI